KRAS and neoplasm: No further statistically significant associations were found between the mutational status of KRAS, NRAS, BRAF and TP53 and patient age, the histological subtype of the tumor, tumor stage, presence of lymph node involvement and metastases, tumor size, CEA serum levels and the presence of perineural invasion.